XPC and glioblastoma: Significantly, our data demonstrate that pharmacological inhibition of USP7 with P22077 induces the degradation of MGMT, XPC, ALKBH2, and ALKBH3, consequently impairing all three major alkylation repair pathways in GBM cells.